[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Quantumup1 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1060595604022280192.png) quantumup [@Quantumup1](/creator/twitter/Quantumup1) on x 3517 followers
Created: 2025-07-09 13:06:19 UTC

Stephens🏁 $PRCT Overweight-$70 and said "Premium Price, Premium Potential: A Surgical Disruptor in BPH; Initiating OW-Vol./$70 PT"
$BSX $ISRG $SYK $MDT $GEHC
#BPH #PCa
Stephens said in its note that it expects $PRCT to post robust growth and margin expansion as adoption of Aquablation continues to expand.

Stephens added:
● Aquablation is disrupting the benign prostatic hyperplasia (BPH) market by taking share from existing procedures and capturing patients who historically delayed or avoided surgery.

● Believes expanding into prostate cancer has the potential to drive meaningful growth longer-term.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942933333446463982/c:line.svg)

**Related Topics**
[adoption](/topic/adoption)
[$gehc](/topic/$gehc)
[$prct](/topic/$prct)
[$bsx](/topic/$bsx)
[boston scientific](/topic/boston-scientific)
[stocks healthcare](/topic/stocks-healthcare)
[$isrg](/topic/$isrg)
[$syk](/topic/$syk)

[Post Link](https://x.com/Quantumup1/status/1942933333446463982)